Pamela Stephenson Albireo Pharma, Inc. (ALBO) insider trading activity

Pamela Stephenson is Chief Commercial Officer of ALBIREO PHARMA, INC.. Currently has a direct ownership of 0 shares of ALBO, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 22,242 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Pamela Stephenson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	22,242 Reduced 100.0%	0 Common Stock
Jan 23 2023	SELL Open market or private sale	$4,467 $43.8 p/Share	102 Reduced 0.24%	42,755 Common Stock
Jan 19 2023	SELL Open market or private sale	$77,878 $43.9 p/Share	1,774 Reduced 3.97%	42,857 Common Stock
Jan 19 2023	BUY Grant, award, or other acquisition	-	55,000 Added 36.01%	97,755 Common Stock
Dec 27 2022	SELL Open market or private sale	$8,939 $19.06 p/Share	469 Reduced 1.03%	45,178 Common Stock
Oct 24 2022	SELL Open market or private sale	$2,036 $19.58 p/Share	104 Reduced 0.23%	45,647 Common Stock
Sep 26 2022	SELL Open market or private sale	$8,633 $19.4 p/Share	445 Reduced 0.96%	45,751 Common Stock
Jul 22 2022	SELL Open market or private sale	$2,615 $24.67 p/Share	106 Reduced 0.23%	46,196 Common Stock
Jun 27 2022	SELL Open market or private sale	$8,976 $19.47 p/Share	461 Reduced 1.0%	45,755 Common Stock
Apr 22 2022	SELL Open market or private sale	$3,391 $32.92 p/Share	103 Reduced 0.22%	46,216 Common Stock
Mar 28 2022	SELL Open market or private sale	$13,856 $30.52 p/Share	454 Reduced 0.97%	46,319 Common Stock
Jan 24 2022	SELL Open market or private sale	$10,350 $24.88 p/Share	416 Reduced 0.88%	46,773 Common Stock
Jan 18 2022	BUY Grant, award, or other acquisition	-	21,600 Added 31.4%	47,189 Common Stock
Dec 27 2021	SELL Open market or private sale	$11,338 $23.92 p/Share	474 Reduced 1.82%	25,589 Common Stock
Sep 27 2021	SELL Open market or private sale	$14,455 $32.05 p/Share	451 Reduced 1.7%	26,063 Common Stock
Jun 25 2021	SELL Open market or private sale	$16,961 $36.01 p/Share	471 Reduced 1.75%	26,514 Common Stock
Mar 29 2021	SELL Open market or private sale	$14,356 $34.02 p/Share	422 Reduced 1.54%	26,985 Common Stock
Jan 21 2021	BUY Grant, award, or other acquisition	-	5,500 Added 16.71%	27,407 Common Stock
Dec 28 2020	SELL Open market or private sale	$17,972 $39.07 p/Share	460 Reduced 2.06%	21,907 Common Stock

Also insider at

ZYNE

Zynerba Pharmaceuticals, Inc. Healthcare

GMTX

Gemini Therapeutics, Inc. Healthcare

Chief Commercial Officer